Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Eisai Enters into Research Agreement with Broad Institute 14
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 15
Broad Institute Genomic Services Partners with Takeda Pharma 16
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 17
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 18
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 19
Eisai Enters into Research Agreement with Broad Institute 20
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 21
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 22
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 27
Licensing Agreements 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 30
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 32
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 34
Evotec Enters into Licensing Agreement with Broad Institute 35
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 36
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 37
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 38
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 39
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 40
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
Applied Stemcell Enters into licensing Agreement with Broad Institute 42
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 43
The Broad Institute Inc – Key Competitors 44
The Broad Institute Inc – Key Employees 45
The Broad Institute Inc – Locations And Subsidiaries 46
Head Office 46
Other Locations & Subsidiaries 46
Recent Developments 47
Strategy And Business Planning 47
Oct 10, 2017: Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare 47
Government and Public Interest 48
Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 48
Product News 50
May 18, 2017: Cohen Veterans Bioscience and the Broad Institute’s Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress Disorder 50
Other Significant Developments 51
Jul 10, 2017: Broad Institute of MIT and Harvard Joins Discussions to Create Worldwide CRISPR-Cas9 Licensing Pool 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
The Broad Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 10
The Broad Institute Inc, Medical Devices Deals, 2011 to YTD 2017 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Eisai Enters into Research Agreement with Broad Institute 14
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 15
Broad Institute Genomic Services Partners with Takeda Pharma 16
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 17
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 18
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 19
Eisai Enters into Research Agreement with Broad Institute 20
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 21
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 22
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 23
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 25
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 26
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 27
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 28
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 30
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 32
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 34
Evotec Enters into Licensing Agreement with Broad Institute 35
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 36
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 37
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 38
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 39
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 40
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 41
Applied Stemcell Enters into licensing Agreement with Broad Institute 42
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 43
The Broad Institute Inc, Key Competitors 44
The Broad Institute Inc, Key Employees 45
The Broad Institute Inc, Other Locations 46
The Broad Institute Inc, Subsidiaries 46